{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T08:29:37Z","timestamp":1775032177592,"version":"3.50.1"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Long-term immunosuppression following transplantation places recipients at a high risk of malignancy. Hepatocellular carcinoma (HCC) recurrence after transplantation poses significant challenges to long-term survival of recipients. Several studies in transplant oncology have established cancer-transplant models to support the development of therapies for reducing the risk of post-transplant cancer recurrence. However, existing models fail to recapitulate the complex immune status of recipients and the authentic tumor microenvironment after transplantation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      C57BL\/6 recipient mice were injected intravenously with luciferase-expressing Hepa1-6 cells 7 days before receiving Balb\/c cardiac allografts, followed by post-transplant immunosuppression with tacrolimus. On day 7 post-transplantation, the immune state of recipients was assessed by measuring serum inflammatory cytokines, and allograft rejection was evaluated by hematoxylin-eosin staining. Cancer progression was evaluated using\n                      <jats:italic>in vivo<\/jats:italic>\n                      imaging and measurements of serum alpha-fetoprotein levels, with subsequent histological confirmation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Allogeneic cardiac transplantation resulted in a significant increase in serum levels of pro-inflammatory cytokines accompanied by a marked reduction in cancer burden. Marked lymphocytic infiltration, hemorrhage, and structural disintegration were observed in the grafts of untreated animals. In contrast, tacrolimus treatment effectively attenuated both the inflammatory cytokine response and acute allograft rejection but, conversely, resulted in a significant increase in tumor burden. Histological analysis confirmed that malignancies were exclusively localized to the lungs, mirroring the most common site of clinical HCC recurrence post-transplantation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This model effectively simulates the elevated risk of cancer recurrence under post-transplant immunosuppression and faithfully recapitulates lung metastasis of HCC mediated by circulating cancer cells\u2014the most common site of clinical recurrence following liver transplantation for HCC. It thus provides a reliable tool for basic research aimed at reducing risk of post-transplant cancer recurrence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcell.2026.1796566","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T05:39:49Z","timestamp":1775021989000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Establishing a novel mouse model of tacrolimus-induced post-transplant hepatocellular carcinoma pulmonary recurrence for transplant oncology"],"prefix":"10.3389","volume":"14","author":[{"given":"Jinliang","family":"Duan","sequence":"first","affiliation":[{"name":"Nankai University School of Medicine","place":["Tianjin, China"]},{"name":"Tianjin Organ Transplantation Research Center, Tianjin First Central Hospital","place":["Tianjin, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Chen","sequence":"additional","affiliation":[{"name":"Nankai University School of Medicine","place":["Tianjin, China"]},{"name":"Tianjin Organ Transplantation Research Center, Tianjin First Central Hospital","place":["Tianjin, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaofeng","family":"Chen","sequence":"additional","affiliation":[{"name":"Nankai University School of Medicine","place":["Tianjin, China"]},{"name":"Tianjin Organ Transplantation Research Center, Tianjin First Central Hospital","place":["Tianjin, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenglu","family":"Wang","sequence":"additional","affiliation":[{"name":"Biological Sample Resource Sharing Center, Tianjin First Central Hospital","place":["Tianjin, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Cao","sequence":"additional","affiliation":[{"name":"Biological Sample Resource Sharing Center, Tianjin First Central Hospital","place":["Tianjin, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zheng","sequence":"additional","affiliation":[{"name":"Tianjin Organ Transplantation Research Center, Tianjin First Central Hospital","place":["Tianjin, China"]},{"name":"Institute of Transplantation Medicine, Nankai University","place":["Tianjin, China"]},{"name":"Tianjin Key Laboratory of Organ Transplantation, Tianjin First Central Hospital","place":["Tianjin, China"]},{"name":"Key Laboratory of Transplant Medicine, Chinese Academy of Medical Science","place":["Tianjin, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongyang","family":"Shen","sequence":"additional","affiliation":[{"name":"Nankai University School of Medicine","place":["Tianjin, China"]},{"name":"Tianjin Organ Transplantation Research Center, Tianjin First Central Hospital","place":["Tianjin, China"]},{"name":"Institute of Transplantation Medicine, Nankai University","place":["Tianjin, China"]},{"name":"Tianjin Key Laboratory of Organ Transplantation, Tianjin First Central Hospital","place":["Tianjin, China"]},{"name":"Key Laboratory of Transplant Medicine, Chinese Academy of Medical Science","place":["Tianjin, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"659","DOI":"10.12659\/AOT.910598","article-title":"Clinical features and surveillance of very late hepatocellular carcinoma recurrence after liver transplantation","volume":"23","author":"Alshahrani","year":"2018","journal-title":"Ann. Transplant."},{"key":"B2","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/ajt.12543","article-title":"De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial","volume":"14","author":"Asrani","year":"2014","journal-title":"Am. Journal Transplantation Official Journal Am. Soc. Transplant. Am. Soc. Transpl. Surg."},{"key":"B3","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/SLA.0000000000001894","article-title":"Predicting mortality in patients developing recurrent hepatocellular carcinoma after liver transplantation: impact of treatment modality and recurrence characteristics","volume":"266","author":"Bodzin","year":"2017","journal-title":"Ann. Surgery"},{"key":"B4","doi-asserted-by":"publisher","first-page":"S204","DOI":"10.1111\/j.1432-2277.1994.tb01347.x","article-title":"Role of immunosuppression in recurrence after liver transplantation for diethylnitrosamine-induced tumors in rats","volume":"7","author":"Ceriello","year":"1994","journal-title":"Transpl. Int. Official J. Eur. Soc. Organ Transplant."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.20892\/j.issn.2095-3941.2024.0267","article-title":"Impact of immunosuppressants on tumor pulmonary metastasis: new insight into transplantation for hepatocellular carcinoma","volume":"21","author":"Chen","year":"2024","journal-title":"Cancer. Biol. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.3389\/fimmu.2020.01044","article-title":"Transplant tolerance induction: insights from the liver","volume":"11","author":"Dai","year":"2020","journal-title":"Front. Immunology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"11185","DOI":"10.3748\/wjg.v21.i39.11185","article-title":"Managements of recurrent hepatocellular carcinoma after liver transplantation: a systematic review","volume":"21","author":"de'Angelis","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1053\/j.gastro.2012.05.052","article-title":"Liver transplantation for hepatocellular carcinoma: a model including \u03b1-fetoprotein improves the performance of milan criteria","volume":"143","author":"Duvoux","year":"2012","journal-title":"Gastroenterology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cell.2019.10.029","article-title":"Differences in tumor microenvironment dictate T helper lineage polarization and response to immune checkpoint therapy","volume":"179","author":"Jiao","year":"2019","journal-title":"Cell"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1097\/00007890-200405150-00002","article-title":"Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice","volume":"77","author":"Koehl","year":"2004","journal-title":"Transplantation"},{"key":"B12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.healun.2022.10.017","article-title":"The dynamic cellular landscape of grafts with acute rejection after heart transplantation","volume":"42","author":"Kong","year":"2023","journal-title":"J. Heart Lung Transplantation The Official Publication Int. Soc. Heart Transplant."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1520083","DOI":"10.3389\/fimmu.2024.1520083","article-title":"Transplant oncology and anti-cancer immunosuppressants","volume":"15","author":"Kong","year":"","journal-title":"Front. Immunology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"112955","DOI":"10.1016\/j.intimp.2024.112955","article-title":"Capecitabine mitigates cardiac allograft rejection via inhibition of TYMS-Mediated Th1 differentiation in mice","volume":"141","author":"Kong","year":"","journal-title":"Int. Immunopharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"100965","DOI":"10.1016\/j.jhepr.2023.100965","article-title":"Transplant oncology - current indications and strategies to advance the field","volume":"6","author":"Krendl","year":"2024","journal-title":"JHEP Rep. Innovation Hepatology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ccell.2024.11.011","article-title":"Cytokines in cancer","volume":"43","author":"Kureshi","year":"2025","journal-title":"Cancer Cell"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1097\/TP.0000000000003394","article-title":"Efficacy and safety of everolimus with reduced tacrolimus in liver transplant recipients: 24-month results from the pooled analysis of 2 randomized controlled trials","volume":"105","author":"Lee","year":"2021","journal-title":"Transplantation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"903","DOI":"10.3748\/wjg.v10.i6.903","article-title":"Disseminated tumor cells homing into rats' liver: a new possible mechanism of HCC recurrence","volume":"10","author":"Li","year":"2004","journal-title":"World J. Gastroenterol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cmet.2014.01.001","article-title":"Rapamycin: one drug, many effects","volume":"19","author":"Li","year":"2014","journal-title":"Cell Metab."},{"key":"B20","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.jhep.2016.05.032","article-title":"CXCL10\/CXCR3 signaling mobilized-regulatory T cells promote liver tumor recurrence after transplantation","volume":"65","author":"Li","year":"2016","journal-title":"J. Hepatology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/s41419-021-03788-4","article-title":"Monocytic MDSC mobilization promotes tumor recurrence after liver transplantation via CXCL10\/TLR4\/MMP14 signaling","volume":"12","author":"Liu","year":"2021","journal-title":"Cell Death and Disease"},{"key":"B22","doi-asserted-by":"publisher","first-page":"111376","DOI":"10.1016\/j.intimp.2023.111376","article-title":"SRSF10 facilitates HCC growth and metastasis by suppressing CD8(+)T cell infiltration and targeting SRSF10 enhances anti-PD-L1 therapy","volume":"127","author":"Luo","year":"2024","journal-title":"Int. Immunopharmacology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"720","DOI":"10.5551\/jat.RV22005","article-title":"Progress in pathological diagnosis after Kidney Transplantation: current trend and future perspective","volume":"30","author":"Masutani","year":"2023","journal-title":"J. Atheroscler. Thromb."},{"key":"B24","first-page":"748","article-title":"Liver transplantation for diethylnitrosamine-induced hepatocellular carcinoma in rats","volume":"24","author":"Matsuzaki","year":"1992","journal-title":"Transplant. Proceedings"},{"key":"B25","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1470-2045(08)70284-5","article-title":"Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis","volume":"10","author":"Mazzaferro","year":"2009","journal-title":"Lancet Oncol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"5790","DOI":"10.3748\/wjg.v22.i25.5790","article-title":"Clinical analysis of patients with hepatocellular carcinoma recurrence after living-donor liver transplantation","volume":"22","author":"Na","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jhep.2014.03.036","article-title":"Pre-retrieval reperfusion decreases cancer recurrence after rat ischemic liver graft transplantation","volume":"61","author":"Oldani","year":"2014","journal-title":"J. Hepatology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e0224890","DOI":"10.1371\/journal.pone.0224890","article-title":"The impact of short-term machine perfusion on the risk of cancer recurrence after rat liver transplantation with donors after circulatory death","volume":"14","author":"Oldani","year":"2019","journal-title":"PloS One"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.7150\/thno.16023","article-title":"The clinical significance and potential therapeutic role of GPx3 in tumor recurrence after liver transplantation","volume":"6","author":"Qi","year":"2016","journal-title":"Theranostics"},{"key":"B31","doi-asserted-by":"publisher","first-page":"177082","DOI":"10.1016\/j.ejphar.2024.177082","article-title":"Oxymatrine attenuates chronic allograft rejection by modulating immune responses and inhibiting fibrosis","volume":"985","author":"Ren","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1111\/ajt.17021","article-title":"Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation","volume":"22","author":"Rodr\u00edguez-Per\u00e1lvarez","year":"2022","journal-title":"Am. J. Transplant. Official J. Am. Soc. Transplant. Am. Soc. Transpl. Surg."},{"key":"B33","doi-asserted-by":"publisher","first-page":"S201","DOI":"10.1007\/s001470050461","article-title":"Hepatocellular carcinoma and liver transplantation: an animal model","volume":"11","author":"Schotman","year":"1998","journal-title":"Transpl. Int. Official J. Eur. Soc. Organ Transplant."},{"key":"B34","doi-asserted-by":"publisher","first-page":"4534","DOI":"10.1038\/s41467-025-58841-z","article-title":"Targeting Setdb1 in T cells induces transplant tolerance without compromising antitumor immunity","volume":"16","author":"Tan","year":"2025","journal-title":"Nat. Commun."},{"key":"B35","doi-asserted-by":"publisher","first-page":"pdb.prot078261","DOI":"10.1101\/pdb.prot078261","article-title":"Quantitative bioluminescence imaging of mouse tumor models","volume":"2015","author":"Tseng","year":"2015","journal-title":"Cold Spring Harb. Protocols"},{"key":"B36","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1097\/TP.0b013e3181b9ca69","article-title":"Suppression of hepatocellular carcinoma recurrence after rat liver transplantation by FTY720, a sphingosine-1-phosphate analog","volume":"88","author":"Ushitora","year":"2009","journal-title":"Transplantation"},{"key":"B37","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/HEP.0000000000000668","article-title":"Benefit and harm of waiting time in liver transplantation for HCC","volume":"82","author":"van der Meeren","year":"2025","journal-title":"Hepatol. Baltim. Md"},{"key":"B38","doi-asserted-by":"publisher","first-page":"88918","DOI":"10.18632\/oncotarget.21493","article-title":"PARP-1 promotes tumor recurrence after warm ischemic liver graft transplantation via neutrophil recruitment and polarization","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"B39","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/lt.23619","article-title":"Sorafenib delays recurrence and metastasis after liver transplantation in a rat model of hepatocellular carcinoma with high expression of phosphorylated extracellular signal-regulated kinase","volume":"19","author":"Yan","year":"2013","journal-title":"Liver Transpl. Official Publication Am. Assoc. Study Liver Dis. Int. Liver Transplant. Soc."},{"key":"B40","doi-asserted-by":"publisher","first-page":"104594","DOI":"10.1016\/j.ebiom.2023.104594","article-title":"A nanotherapeutic strategy that engages cytotoxic and immunosuppressive activities for the treatment of cancer recurrence following organ transplantation","volume":"92","author":"Yang","year":"2023","journal-title":"EBioMedicine"},{"key":"B41","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1046\/j.1525-1500.1998.0oa28.x","article-title":"The outcome of liver transplantation at various times (70, 120, and 134 days) after the initiation of carcinogenesis in rats","volume":"22","author":"Yano","year":"1998","journal-title":"Cancer Detect. Prev."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1111\/jgh.16693","article-title":"Recurrence risk prediction models for hepatocellular carcinoma after liver transplantation","volume":"39","author":"Zhang","year":"2024","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/ame2.12335","article-title":"Establishment of image-guided radiotherapy of orthotopic hepatocellular carcinoma mouse model","volume":"6","author":"Zhou","year":"2023","journal-title":"Anim. Models Exp. Med."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1796566\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T05:39:50Z","timestamp":1775021990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1796566\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":43,"alternative-id":["10.3389\/fcell.2026.1796566"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2026.1796566","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"article-number":"1796566"}}